ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis

Xu Suowen*; Liu Zhiping; Liu PeiqingNIH
International Journal of Cardiology2014-3-15
12被引7阅读
引用收藏
分享

摘要

Physiological concentrations of nitric oxide (NO) and carbon monoxide (CO) have multiple protective effects in the cardiovascular system. Recent studies have implicated hydrogen sulfide (H2S) as a new member of vasculoprotective gasotransmitter family, behaving similarly to NO and CO. H2S has been demonstrated to inhibit multiple key aspects of atherosclerosis, including atherogenic modification of LDL, monocytes adhesion to the endothelial cells, macrophage-derived foam cell formation and inflammation, smooth muscle cell proliferation, neointimal hyperplasia, vascular calcification, and thrombogenesis. H2S also decreases plasma homocysteine levels in experimental animal models. In the human body, H2S production is predominantly catalyzed by cystathionine-beta-synthase (CBS) and cystathionine.-lyase (CSE). CSE is the primary H2S-producing enzyme in the vasculature. Growing evidence suggests that atherosclerosis is associated with vascular CSE/H2S deficiency and that H2S supplementation by exogenous H2S donors (such as NaHS and GYY4137) attenuates, and H2S synthesis suppression by inhibitors (such as D, L-propargylglycine) aggravates the development of atherosclerotic plaques. However, it remains elusive whether CSE deficiency plays a causative role in atherosclerosis. A recent study (Circulation. 2013; 127: 2523-2534) demonstrates that decreased endogenous H2S production by CSE genetic deletion accelerates atherosclerosis in athero-prone ApoE(-/-) mice, pinpointing that endogenously produced H2S by CSE activation may be of benefit in the prevention and treatment of atherosclerosis. This study will facilitate the development of H2S-based pharmaceuticals with therapeutic applications in atherosclerosis-related cardiovascular diseases.

学科与关键词

关键词
AtherosclerosisCystathionine gamma-lyaseGasotransmitterHydrogen sulfide
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Journal of Cardiology
发表日期
2014-03-15
卷期
第 172 卷, 第 2 期
页码
313-317
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCI
资助标注
National Natural Science Foundation of China [81072641, 81273499]; National Science and Technology Major Project of China "Key New Drug Creation and Manufacturing Program" [2011ZX09401-307]; Team Item of the Natural Science Foundation of Guangdong Province [S2011030003190]; Major Project of Guangdong Province [2008A030201013, 2012A080201007]; Major Project of Department of Education of Guangdong Province [CXZD1006]; Ministry of Education of China

作者

  • X

    Xu Suowen (通讯) (第一作者)

    nih

  • L

    Liu Zhiping

查看全部 3 位作者收起作者
  • L

    Liu Peiqing

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417